| Peroxisome proliferator–activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis H Kim, M Haluzik, Z Asghar, D Yau, JW Joseph, AM Fernandez, ... Diabetes 52 (7), 1770-1778, 2003 | 217 | 2003 |
| Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes Z Asghar, D Yau, F Chan, D Leroith, CB Chan, MB Wheeler Diabetologia 49, 90-99, 2006 | 99 | 2006 |
| Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice L Héron-Milhavet, M Haluzik, S Yakar, O Gavrilova, S Pack, WC Jou, ... Endocrinology 145 (10), 4667-4676, 2004 | 87 | 2004 |
| Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased β-cell mass in mice lacking the p110γ isoform of phosphoinositide 3-kinase PE MacDonald, JW Joseph, D Yau, J Diao, Z Asghar, F Dai, GY Oudit, ... Endocrinology 145 (9), 4078-4083, 2004 | 58 | 2004 |
| Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389 D Yau, TW Laver, A Dastamani, S Senniappan, JAL Houghton, G Shaikh, ... PLoS One 15 (2), e0228417, 2020 | 36 | 2020 |
| Diazoxide‐induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom SC Chen, A Dastamani, D Pintus, D Yau, S Aftab, L Bath, C Swinburne, ... Clinical Endocrinology 91 (6), 770-775, 2019 | 35 | 2019 |
| Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus D Yau, E De Franco, SE Flanagan, S Ellard, M Blumenkrantz, JJ Mitchell Diagnostic Pathology 12, 1-7, 2017 | 34 | 2017 |
| Unravelling the genetic causes of mosaic islet morphology in congenital hyperinsulinism JAL Houghton, I Banerjee, G Shaikh, S Jabbar, TW Laver, E Cheesman, ... The Journal of Pathology: Clinical Research 6 (1), 12-16, 2020 | 31 | 2020 |
| Complexities in the medical management of hypoglycaemia due to congenital hyperinsulinism C Worth, D Yau, M Salomon Estebanez, E O’shea, K Cosgrove, M Dunne, ... Clinical endocrinology 92 (5), 387-395, 2020 | 22 | 2020 |
| Decreased KATP Channel Activity Contributes to the Low Glucose Threshold for Insulin Secretion of Rat Neonatal Islets J Yang, B Hammoud, C Li, A Ridler, D Yau, J Kim, KJ Won, CA Stanley, ... Endocrinology 162 (9), bqab121, 2021 | 21 | 2021 |
| Clinical diversity in focal congenital hyperinsulinism in infancy correlates with histological heterogeneity of islet cell lesions RJ Craigie, M Salomon-Estebanez, D Yau, B Han, W Mal, M Newbould, ... Frontiers in endocrinology 9, 619, 2018 | 14 | 2018 |
| Efficacy of dose-titrated glucagon infusions in the management of congenital hyperinsulinism: A case series M Salomon-Estebanez, D Yau, MJ Dunne, C Worth, S Birch, JL Walewski, ... Frontiers in Endocrinology 11, 547703, 2020 | 12 | 2020 |
| Longitudinal Auxological recovery in a cohort of children with Hyperinsulinaemic Hypoglycaemia C Worth, LA Hashmi, D Yau, M Salomon-Estebanez, DP Ruiz, C Hall, ... Orphanet Journal of Rare Diseases 15, 1-9, 2020 | 11 | 2020 |
| Congenital hyperinsulinism due to mutations in HNF1A D Yau, K Colclough, A Natarajan, R Parikh, N Canham, M Didi, ... European Journal of Medical Genetics 63 (6), 103928, 2020 | 9 | 2020 |
| PPAR-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis H Kim, M Haluzik, Z Asghar, D Yau, J Joseph, A Fernandez, M Reitman, ... Diabetes 52 (7), 1770-1778, 2003 | 6 | 2003 |
| Central venous catheter-associated thrombosis in children with congenital hyperinsulinism D Yau, M Salomon-Estebanez, A Chinoy, J Grainger, RJ Craigie, ... Endocrinology, diabetes & metabolism case reports 2019 (1), 2019 | 5 | 2019 |
| Variation in glycemic outcomes in focal forms of congenital hyperinsulinism—The UK perspective A Dastamani, D Yau, C Gilbert, K Morgan, P De Coppi, RJ Craigie, ... Journal of the Endocrine Society 6 (6), bvac033, 2022 | 4 | 2022 |
| Diazoxide-responsive forms of congenital hyperinsulinism D Yau, CA Stanley Congenital Hyperinsulinism: A Practical Guide to Diagnosis and Management, 15-32, 2019 | 4 | 2019 |
| Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11 TI Hewat, D Yau, JCS Jerome, TW Laver, JAL Houghton, BM Shields, ... European journal of endocrinology 185 (6), 813-818, 2021 | 2 | 2021 |
| Clinical outcomes of focal congenital hyperinsulinism-a UK perspective A Dastamani, D Yau, C Gilbert, K Morgan, O Elaine, H Pimlott, P DeCoppi, ... Endocrine Abstracts 58, 2018 | 2 | 2018 |
